Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine|DRUG: doxorubicin|DRUG: cisplatin|PROCEDURE: surgery
Sponsor: Eli Lilly and Company